A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after strokeJohn W. Dunne, Barbara Singer, Mike Hayes et al.|Clinical Rehabilitation|2012Cited by 60